Dr. Eric B. Larson, a report contributor, answers questions about reducing risks, disparities, and threats from COVID-19.
National Institute of Allergy and Infectious Diseases-sponsored phase 1 trial tested mRNA vaccine.
Dr. Mike Jackson has long studied the spread of flu and effectiveness of vaccination at Kaiser Permanente Washington. And now… of COVID-19 too.
Older people must guard against social isolation, as well as COVID-19, to stay well and thrive, writes Dr. Eric B. Larson.
Melissa Parson shares 4 lessons she learned while on assignment with Kaiser Permanente Washington diabetes nurses.
KPWHRI’s Dr. Michael Jackson describes how better testing will improve our ability to forecast the pandemic’s path.
Now more than ever we can benefit from studies embedded in health-care systems to answer common clinical questions.